What is Wave Life Sciences's change in accrued liabilities?

Wave Life Sciences (WVE) reported change in accrued liabilities of -$13.52M in Q1 2026.

How has Wave Life Sciences's change in accrued liabilities changed year-over-year?

Wave Life Sciences's change in accrued liabilities decreased by 1.9% year-over-year, from -$13.27M to -$13.52M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Wave Life Sciences WVE Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Sarepta Therapeutics, Inc.SRPT

-$60.03M-290%

Madrigal Pharmaceuticals, Inc.MDGL

$4.29M+909%

Beam TherapeuticsBEAM

-$16.26M+11.9%

Amylyx Pharmaceuticals, Inc.AMLX

-$6.67M+43.8%

MeiraGTx Holdings plcMGTX

-$9.9M-176%

Intellia TherapeuticsNTLA

-$11.95M+17.1%

Other financials

Income statement

See full

Revenue$38.2M+317%

Operating income-$31.3M+37.2%

Net income-$26.1M+44.4%

EPS (diluted)-$0.13+55.2%

Balance sheet

See full

Cash & equivalents$544.6M+124%

Total debt$15.7M-33.4%

Total equity$511.7M+198%

Total assets$583.5M+102%

Cash flow

See full

Operating cash flow-$59.6M+5.5%

CapEx$438.0K+165%

Free cash flow-$60.0M+5.1%

Valuation

See full

Market cap$1.14B+13.0%

Enterprise value$615.92M-22.3%

P/S15.1×-12.2×

Profitability

See full

Operating margin-75.7%-33.6pp

Net margin-66.5%-29.9pp

FCF margin-27.2%-12.6pp

Returns & leverage

See full

Return on equity-53.7%—

Debt / equity0×-0.1×

Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's change in accrued liabilities?: Wave Life Sciences (WVE) reported change in accrued liabilities of -$13.52M in Q1 2026.
How has Wave Life Sciences's change in accrued liabilities changed year-over-year?: Wave Life Sciences's change in accrued liabilities decreased by 1.9% year-over-year, from -$13.27M to -$13.52M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.